Evidence-Based Reviews

Telepsychiatry: What you need to know

Author and Disclosure Information

 

References

Medicaid is the single largest payer for mental health services in the United States,29 and all Medicaid programs reimburse for some telepsychiatry services. As with all Medicaid health care, fees paid for telepsychiatry are state-specific. Since 2013, several state Medicaid programs, including New York,30 have expanded the list of eligible telehealth sites to include schools, thereby giving children virtual access to mental health clinicians.

Getting started

Clinicians who are interested in starting to provide treatment via telepsychiatry can begin by reviewing the American Psychiatric Association’s Telepsychiatry Toolkit at www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit. This toolkit, which is being continually updated, features numerous training videos for clinicians new to telepsychiatry, such as Learning To Do Telemental Health (www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit/learning-telemental-health) and The Credentialing Process (www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit/credentialing-process). Before starting, also consider reviewing the steps listed in Table 2.

Telepsychiatry: 8 Steps to consider before starting

Bottom Line

Evidence suggests telepsychiatry can be beneficial for a wide range of patient populations and settings. Most patients accept its use, and some actually prefer it to face-to-face care. Telepsychiatry may be especially useful for patients who have limited access to psychiatric treatment, such as those who live in rural areas. Factors to consider before incorporating telepsychiatry into your practice include addressing various legal, technological, and financial requirements.

Related Resources

Pages

Recommended Reading

ACE inhibitors and severe COVID-19: Protective in older patients?
MDedge Psychiatry
COVID-19 and Mental Health Awareness Month
MDedge Psychiatry
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
MDedge Psychiatry
Neuropsychiatric manifestations of COVID-19
MDedge Psychiatry
Life during COVID-19: A pandemic of silence
MDedge Psychiatry
Telepsychiatry during COVID-19: Understanding the rules
MDedge Psychiatry
Armchair epidemiology
MDedge Psychiatry
Remdesivir shortens COVID-19 time to recovery in published study
MDedge Psychiatry
Changes in patient behavior during COVID-19: What I’ve observed
MDedge Psychiatry
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
MDedge Psychiatry